Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Ldlrad3 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LDLRAD3 mRNA | CTD | PMID:22079256 | Ldlrad3 | Rat | (S)-nicotine | increases splicing | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Nicotine results in increased splicing of LDLRAD3 mRNA alternative form | CTD | PMID:23825647 | Ldlrad3 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of LDLRAD3 mRNA | CTD | PMID:22206623 | Ldlrad3 | Rat | 17beta-estradiol | increases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Estradiol results in increased expression of LDLRAD3 mRNA | CTD | PMID:23019147|PMID:31614463 | Ldlrad3 | Rat | 17beta-estradiol | decreases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | Estradiol results in decreased expression of LDLRAD3 mRNA | CTD | PMID:39298647 | Ldlrad3 | Rat | 17beta-estradiol | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of LDLRAD3 mRNA | CTD | PMID:30165855 | Ldlrad3 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of LDLRAD3 mRNA | CTD | PMID:29581250 | Ldlrad3 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Ldlrad3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased more ... | CTD | PMID:28433925 | Ldlrad3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Ldlrad3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased more ... | CTD | PMID:28433925 | Ldlrad3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LDLRAD3 mRNA | CTD | PMID:32109520 | Ldlrad3 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of LDLRAD3 mRNA | CTD | PMID:32109520 | Ldlrad3 | Rat | acrylamide | decreases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of LDLRAD3 mRNA | CTD | PMID:32763439 | Ldlrad3 | Rat | aflatoxin B1 | decreases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of LDLRAD3 mRNA | CTD | PMID:19770486 | Ldlrad3 | Rat | aflatoxin B1 | increases methylation | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of LDLRAD3 intron | CTD | PMID:30157460 | Ldlrad3 | Rat | all-trans-retinoic acid | decreases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of LDLRAD3 mRNA | CTD | PMID:21934132|PMID:33167477 | Ldlrad3 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LDLRAD3 mRNA | CTD | PMID:35163327 | Ldlrad3 | Rat | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of LDLRAD3 mRNA | CTD | PMID:30779732 | Ldlrad3 | Rat | aristolochic acid A | decreases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of LDLRAD3 mRNA | CTD | PMID:33212167 | Ldlrad3 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of LDLRAD3 gene | CTD | PMID:28931070 | Ldlrad3 | Rat | benzo[a]pyrene | decreases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of LDLRAD3 mRNA | CTD | PMID:19770486|PMID:20713471|PMID:21715664 | Ldlrad3 | Rat | benzo[a]pyrene | increases methylation | ISO | Ldlrad3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of LDLRAD3 intron | CTD | PMID:27901495 | Ldlrad3 | Rat | benzo[a]pyrene | increases methylation | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of LDLRAD3 promoter | CTD | PMID:27901495 | Ldlrad3 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LDLRAD3 mRNA | CTD | PMID:19150397 | Ldlrad3 | Rat | benzo[b]fluoranthene | decreases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in decreased expression of LDLRAD3 mRNA | CTD | PMID:26377693 | Ldlrad3 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Ldlrad3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased more ... | CTD | PMID:28433925 | Ldlrad3 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of LDLRAD3 mRNA | CTD | PMID:30816183 | Ldlrad3 | Rat | bisphenol A | decreases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of LDLRAD3 mRNA | CTD | PMID:33221593 | Ldlrad3 | Rat | bisphenol A | multiple interactions | ISO | Ldlrad3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased more ... | CTD | PMID:28433925 | Ldlrad3 | Rat | Butylbenzyl phthalate | increases methylation | ISO | Ldlrad3 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of LDLRAD3 intron | CTD | PMID:28392331 | Ldlrad3 | Rat | cadmium atom | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LDLRAD3 more ... | CTD | PMID:35301059 | Ldlrad3 | Rat | cadmium atom | multiple interactions | ISO | Ldlrad3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LDLRAD3 more ... | CTD | PMID:37325564 | Ldlrad3 | Rat | cadmium dichloride | decreases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of LDLRAD3 mRNA | CTD | PMID:38568856 | Ldlrad3 | Rat | cadmium dichloride | multiple interactions | ISO | Ldlrad3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LDLRAD3 more ... | CTD | PMID:37325564 | Ldlrad3 | Rat | cadmium dichloride | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LDLRAD3 more ... | CTD | PMID:35301059 | Ldlrad3 | Rat | carbon nanotube | decreases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | Nanotubes, Carbon results in decreased expression of LDLRAD3 mRNA | CTD | PMID:25554681 | Ldlrad3 | Rat | cisplatin | decreases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of LDLRAD3 mRNA | CTD | PMID:27594783 | Ldlrad3 | Rat | Dibutyl phosphate | affects expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of LDLRAD3 mRNA | CTD | PMID:37042841 | Ldlrad3 | Rat | dioxygen | increases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of LDLRAD3 mRNA | CTD | PMID:24205000 | Ldlrad3 | Rat | disodium selenite | increases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of LDLRAD3 mRNA | CTD | PMID:18175754 | Ldlrad3 | Rat | dorsomorphin | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Ldlrad3 | Rat | ethanol | affects splicing | ISO | Ldlrad3 (Mus musculus) | 6480464 | Ethanol affects the splicing of LDLRAD3 mRNA | CTD | PMID:30319688 | Ldlrad3 | Rat | folic acid | increases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | Folic Acid results in increased expression of LDLRAD3 mRNA | CTD | PMID:25629700 | Ldlrad3 | Rat | gardiquimod | increases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | gardiquimod results in increased expression of LDLRAD3 mRNA | CTD | PMID:28003376 | Ldlrad3 | Rat | gardiquimod | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of LDLRAD3 mRNA] | CTD | PMID:28003376 | Ldlrad3 | Rat | lead diacetate | increases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | lead acetate results in increased expression of LDLRAD3 mRNA | CTD | PMID:21829687 | Ldlrad3 | Rat | lipopolysaccharide | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of LDLRAD3 mRNA] | CTD | PMID:35811015 | Ldlrad3 | Rat | lipopolysaccharide | increases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of LDLRAD3 mRNA | CTD | PMID:35811015 | Ldlrad3 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of LDLRAD3 gene | CTD | PMID:35440735 | Ldlrad3 | Rat | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of LDLRAD3 gene | CTD | PMID:33148267 | Ldlrad3 | Rat | nicotine | increases splicing | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Nicotine results in increased splicing of LDLRAD3 mRNA alternative form | CTD | PMID:23825647 | Ldlrad3 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LDLRAD3 mRNA | CTD | PMID:35163327 | Ldlrad3 | Rat | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of LDLRAD3 gene | CTD | PMID:33148267 | Ldlrad3 | Rat | phenobarbital | affects expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | Phenobarbital affects the expression of LDLRAD3 mRNA | CTD | PMID:23091169 | Ldlrad3 | Rat | phenylmercury acetate | decreases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of LDLRAD3 mRNA | CTD | PMID:26272509 | Ldlrad3 | Rat | phenylmercury acetate | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Ldlrad3 | Rat | potassium chromate | decreases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of LDLRAD3 mRNA | CTD | PMID:22079256 | Ldlrad3 | Rat | potassium chromate | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LDLRAD3 mRNA | CTD | PMID:22079256 | Ldlrad3 | Rat | protein kinase inhibitor | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of LDLRAD3 mRNA] | CTD | PMID:28003376 | Ldlrad3 | Rat | rotenone | increases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | Rotenone results in increased expression of LDLRAD3 mRNA | CTD | PMID:32937126 | Ldlrad3 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of LDLRAD3 mRNA] | CTD | PMID:35811015 | Ldlrad3 | Rat | SB 431542 | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Ldlrad3 | Rat | silicon dioxide | increases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of LDLRAD3 mRNA | CTD | PMID:25895662 | Ldlrad3 | Rat | sodium arsenite | decreases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of LDLRAD3 mRNA | CTD | PMID:38568856 | Ldlrad3 | Rat | sodium dodecyl sulfate | decreases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in decreased expression of LDLRAD3 mRNA | CTD | PMID:31734321 | Ldlrad3 | Rat | succimer | multiple interactions | ISO | Ldlrad3 (Mus musculus) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LDLRAD3 mRNA | CTD | PMID:26378955 | Ldlrad3 | Rat | sunitinib | increases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of LDLRAD3 mRNA | CTD | PMID:31533062 | Ldlrad3 | Rat | thiram | decreases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Thiram results in decreased expression of LDLRAD3 mRNA | CTD | PMID:38568856 | Ldlrad3 | Rat | titanium dioxide | decreases methylation | ISO | Ldlrad3 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of LDLRAD3 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Ldlrad3 | Rat | titanium dioxide | decreases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of LDLRAD3 mRNA | CTD | PMID:35295148 | Ldlrad3 | Rat | trichostatin A | decreases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of LDLRAD3 mRNA | CTD | PMID:26272509 | Ldlrad3 | Rat | trichostatin A | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Ldlrad3 | Rat | triptonide | decreases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | triptonide results in decreased expression of LDLRAD3 mRNA | CTD | PMID:33045310 | Ldlrad3 | Rat | trovafloxacin | decreases expression | ISO | Ldlrad3 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of LDLRAD3 mRNA | CTD | PMID:35537566 | Ldlrad3 | Rat | valproic acid | decreases expression | ISO | LDLRAD3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of LDLRAD3 mRNA | CTD | PMID:23179753|PMID:26272509|PMID:37505509 | Ldlrad3 | Rat | valproic acid | multiple interactions | ISO | LDLRAD3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















